NEW YORK, Jan. 22, 2021 /PRNewswire/ -- The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals' LupkynisTM (voclosporin) as the first oral treatment developed specifically for adults with active...
from PR Newswire: https://ift.tt/3o3Larm
No comments:
Post a Comment